ArticleAnnals of medicine2025
Early detection of cognitive impairment in the general population through a digital tool targeting the prospective memory. A pilot study.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Precision Computational Framework for sLORETA Neurofeedback in Mild Cognitive Impairment: Integration of qEEG Biomarkers and Neuropsychological Metrics.International journal of environmental research and public health · 2026Article
- From cognitive screening to digital phenotyping: rethinking early detection of cognitive impairment in primary care.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBased on Prospective Memory (PM), we developed a digitalized tool (Chrono) aimed at the detection of cognitive dysfunction. It incorporated event-based tasks signaled by focal/non-focal cues.
methodThe validation group consisted of 67 individuals (
resultsChrono score achieved an AUC = 0.813. According to sensitivity (0.83) and specificity (0.64), the optimal cut-off of 2.5 allowed discriminating between groups (
conclusionAs an exploratory study, our findings partially support the potential application of Chrono as a digital screening device for cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.